Adams Diversified Equity Fund’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.5M Hold
145,000
– – 0.38% 82
2026
Q2
$9.8M Buy
+145,000
New +$9.7M 0.3% 90
2024
Q3
– Sell
-128,057
Closed -$14.5M – 104
2024
Q2
$14.5M Sell
128,057
-66,900
-34% -$8.46M 0.5% 71
2024
Q1
$27M Hold
194,957
– – 0.96% 35
2023
Q4
$24.2M Hold
194,957
– – 0.95% 42
2023
Q3
$18.2M Hold
194,957
– – 0.78% 54
2023
Q2
$25.1M Hold
194,957
– – 1.04% 29
2023
Q1
$22.7M Buy
+194,957
New +$21.8M 1.02% 31

Other funds holding DXCM

Adams Diversified Equity Fund's DXCM Position: Q3 2026 in Review

Adams Diversified Equity Fund held its DexCom (DXCM) position steady in Q3 2026 at 145,000 shares worth $12.5M. The position accounts for 0.38% of the portfolio, ranked #82.

Adams Diversified Equity Fund first reported a position in DXCM in Q1 2023 and has held it in 8 quarters since. The position peaked at $27M in Q1 2024. 1,056 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Adams Diversified Equity Fund held 145,000 shares of DexCom worth $12.5M as of Q3 2026.
  • Adams Diversified Equity Fund left its DexCom share count unchanged in Q3 2026.
  • DexCom made up 0.38% of Adams Diversified Equity Fund's portfolio in Q3 2026, its #82 holding.
  • Adams Diversified Equity Fund first reported a position in DexCom in Q1 2023 and has held it in 8 quarters since.
  • Adams Diversified Equity Fund's DexCom position peaked at $27M in Q1 2024.
  • 1,056 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Adams Diversified Equity Fund's 13F filing for Q3 2026, filed 21 Oct 2026.